Clinical laboratory
Healthcare issues related to clinical laboratories;
 
H.R. 4128/S. 2209, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, provisions relating to FDA oversight of laboratory-developed tests;
 
Federal policy related to implementation of the Families First Coronavirus Response Act, Pub. L. 116-127, provisions relating to coverage of and funding for COVID-19 diagnostic tests;
 
Federal policy related to implementation of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, Pub. L. 116-136, provisions relating to coverage and reimbursement of COVID-19 diagnostic tests and Medicare reimbursement for clinical laboratory tests;
  
Federal policy relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; and
 
Federal policy relating to pandemic preparedness, improvements in clinical research processes, and advancement of genetic and genomic testing, including a discussion draft of the Cures 2.0 Act;
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
KELLEY DRYE & WARREN LLP
3050 K STREET, NW, SUITE 400, WASHINGTON, DC, 20007, US
DANA SCHNEEBERGER WOOD SCOTT MCGEE